机构:[1]State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, 518055, People’s Republic of China[2]Institute of Forensic Injury, Institute of Forensic Bio-Evidence, Western China Science and Technology Innovation Harbor, Xi’an Jiaotong University, Xi’an, People’s Republic of China[3]Hospital of Chengdu, University of Traditional Chinese Medicine, No.39 Shi-er-qiao Road, Chengdu, People’s Republic of China[4]Department of Pediatrics, Shenzhen University General Hospital, Shenzhen University, People’s Republic of China深圳大学总医院深圳市康宁医院深圳医学信息中心[5]Cancer Center, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, People’s Republic of China[6]Institute of Chemical Biology, Shenzhen Bay Laboratory, People’s Republic of China
第一作者机构:[1]State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, 518055, People’s Republic of China
通讯作者:
通讯机构:[1]State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, 518055, People’s Republic of China[6]Institute of Chemical Biology, Shenzhen Bay Laboratory, People’s Republic of China
推荐引用方式(GB/T 7714):
Gao Ruyan,Ali Tahir,Liu Zizhen,et al.Ceftriaxone averts neuroinflammation and relieves depressive-like behaviors via GLT-1/TrkB signaling[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2024,701:149550.doi:10.1016/j.bbrc.2024.149550.
APA:
Gao Ruyan,Ali Tahir,Liu Zizhen,Li Axiang,Hao Liangliang...&Li Shupeng.(2024).Ceftriaxone averts neuroinflammation and relieves depressive-like behaviors via GLT-1/TrkB signaling.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,701,
MLA:
Gao Ruyan,et al."Ceftriaxone averts neuroinflammation and relieves depressive-like behaviors via GLT-1/TrkB signaling".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 701.(2024):149550